Sort   by:  
 Page size 
UnknownPharmacodynamic biomarkers for quantifying the mycobacterial effect of high doses of rifampin in patients with rifampin-susceptible pulmonary tuberculosis.
Not available
S-EPMC7612567 | biostudies-literature
UnknownHigh dose oral rifampicin to improve survival from adult tuberculous meningitis: A randomised placebo-controlled double-blinded phase III trial (the HARVEST study).
Not available
S-EPMC7542255 | biostudies-literature
UnknownNeurophysiologic correlates of fMRI in human motor cortex.
Not available
S-EPMC6870225 | biostudies-literature
UnknownPharmacokinetics, safety and tolerability of the novel β-hCG derived immunomodulatory compound, EA-230.
Not available
S-EPMC6595371 | biostudies-literature
UnknownRifampicin Can Be Given as Flat-Dosing Instead of Weight-Band Dosing.
Not available
S-EPMC7819529 | biostudies-literature
UnknownKnowledge, attitude and practice of community pharmacy personnel in tuberculosis patient detection: a multicentre cross-sectional study in a high-burden tuberculosis setting.
Not available
S-EPMC9258488 | biostudies-literature
UnknownEnhanced antimycobacterial efficacy of simulated inhaled clofazimine versus oral clofazimine in combination with azithromycin and ethambutol in a hollow-fiber system.
Not available
S-EPMC12802879 | biostudies-literature
UnknownThe role of rifampicin within the treatment of Mycobacterium avium pulmonary disease.
Not available
S-EPMC10649009 | biostudies-literature
UnknownThe Clinical Link between Human Intestinal Microbiota and Systemic Cancer Therapy.
Not available
S-EPMC6747354 | biostudies-literature
UnknownA Population Pharmacokinetic Model Incorporating Saturable Pharmacokinetics and Autoinduction for High Rifampicin Doses.
Not available
S-EPMC5888114 | biostudies-literature
Sort   by:  
 Page size